Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Crofelemer

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,823Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jaguar Health Aims to Expand Canalevia's Use at Health Summit
    Jaguar Health Aims to Expand Canalevia's Use at Health Summit

    21 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-21/jaguar-health-participating-in-august-25-26-animal-health-summit-with-goal-of-securing-collaboration

    PHARMAWEB
    21 Aug 2025
    Share Share
    Jaguar's Proposals Approved at 2025 Annual Stockholders Meeting
    Jaguar's Proposals Approved at 2025 Annual Stockholders Meeting

    19 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-19/jaguar-health-reports-approval-of-all-proposals-at-august-2025-annual-meeting-of-stockholders

    PHARMAWEB
    19 Aug 2025
    Share Share
    Napo Pharma, FDA Discuss Crofelemer for Pediatric MVID Treatment
    Napo Pharma, FDA Discuss Crofelemer for Pediatric MVID Treatment

    19 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-19/jaguar-health-family-company-napo-pharmaceuticals-to-meet-with-fda-to-discuss-potential-regulatory-p

    PHARMAWEB
    19 Aug 2025
    Share Share
    Jaguar Health Seeks EU Approval for Canalevia for Dog Diarrhea
    Jaguar Health Seeks EU Approval for Canalevia for Dog Diarrhea

    25 Jun 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-to-pursue-approval-of-canalevia-in-european-union-for-t-1042839

    ACCESSWIRE
    25 Jun 2025
    Share Share
    Jaguar Health Extends Maturity Date of Convertible Notes to Jan
    Jaguar Health Extends Maturity Date of Convertible Notes to Jan

    24 Jun 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/jaguar-health-announces-extension-of-the-maturity-date-of-its-convert-1042603

    ACCESSWIRE
    24 Jun 2025
    Share Share
    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID
    Jaguar Starts Phase 2 Trial of Crofelemer for Pediatric MVID

    20 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/first-patient-randomized-in-jaguar-healths-phase-2-randomized-double-1029830

    ACCESSWIRE
    20 May 2025
    Share Share